Ascendis Pharma
ASND
#1605
Rank
โ‚ฌ11.38 B
Marketcap
186,37ย โ‚ฌ
Share price
-2.20%
Change (1 day)
58.14%
Change (1 year)

EPS for Ascendis Pharma (ASND)

EPS in 2025 (TTM): -3,86ย โ‚ฌ

According to Ascendis Pharma 's latest financial reports the company's current EPS (TTM) is -3,65ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -6,03ย โ‚ฌ an increase over its 2023 EPS that were of -7,85ย โ‚ฌ.

EPS history for Ascendis Pharma from 2023 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-3,86ย โ‚ฌ-36.03%
2024-6,03ย โ‚ฌ-23.17%
2023-7,85ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Akebia Therapeutics
AKBA
-0,05937ย โ‚ฌ-98.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
-4,43ย โ‚ฌ 21.47%๐Ÿ‡ฉ๐Ÿ‡ช Germany
Advaxis
ADXS.defunct
-8,22ย โ‚ฌ 125.17%๐Ÿ‡บ๐Ÿ‡ธ USA